Systemic lupus erythematosus, or simply lupus, is a disease that can damage any part of the body, including skin, joints, and organs, by causing the body’s natural defense system to attack healthy tissue. It is an autoimmune disease, meaning that the body’s immune system (which produces proteins called antibodies to fight off invaders such as viruses, bacteria, and germs) cannot tell the difference between these invaders and the body’s healthy tissue. As the antibodies attack healthy tissue, it results in inflammation, pain, and damage in various parts of the body, and symptoms tend to get worse during periodic flare-ups. Lupus can develop in people of any age and race or ethnic group, but it is most common among women of childbearing age (15-44), and women of color are two to three times more likely to develop the condition than Caucasians. The severity of lupus can range from mild to life-threatening, and there is no cure, but with good medical care, most people with lupus can lead a relatively full life.
The UAB Division of Clinical Immunology and Rheumatology has consistently been ranked as one of the top 12 clinical rheumatology programs in the country by U.S. News & World Report. It is internationally recognized for its dedication to advancing knowledge and translating research findings into more effective diagnosis and treatment of patients with rheumatic diseases such as rheumatoid arthritis, gout, lupus (systemic lupus erythematosus, or SLE), osteoporosis, scleroderma, dermatomyositis, polymyositis, vasculitis (including Wegener's granulomatosis), and related diseases. As one of the largest academic rheumatology programs in the nation, the division's clinical practice logs more than 10,000 visits annually, evaluating and treating patients with various forms of connective tissue disease. It is staffed by practitioners and specialists in multiple fields, making it easier for physicians to collaborate toward more effective patient care.
Since the division’s formation in the 1950s, our rheumatologists have contributed substantially to the understanding of rheumatic diseases, including their pathogenesis, clinical manifestations, and current diagnostic and therapeutic approaches. They work closely with specialists in musculoskeletal radiology to provide the most advanced imaging techniques and interpretation of radiographs, CT scans, and MRI scans. The Interdisciplinary Infusion Center at The Kirklin Clinic of UAB Hospital provides ready access to the latest FDA-approved intravenous medications for many rheumatic diseases.
With support from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, we launched the UAB Center of Research Translation on Gout and Hyperuricemia. The center includes the UAB Gout Clinic, located within the Rheumatology clinic at The Kirklin Clinic of UAB Hospital, where UAB experts come together in one location to deliver cutting-edge patient care and conduct advanced research on gout, which affects an estimated 4% of the U.S. population. This team combines expertise in rheumatology, nephrology, and cardiology to focus on better understanding how gout is influenced by genetics and environmental factors, with the goal of more accurate diagnoses and increasingly effective treatments.
UAB is an active participant in research and clinical trials. We encourage you to speak to your physician about research and clinical trial options and browse the link below for more information.View Clinical Trials
U.S. News Once Again Names UAB Best Hospital in Alabama
UAB Medicine Uses Music Therapy to Comfort Women after Fetal Loss
UAB Hospital-Highlands COVID Testing Site Closing, Moving to The Kirklin Clinic Parking Deck
UAB Nurse Navigators Guide Patients with Cancer through Challenging Journey
Diet Plans: The Best One for You Is One You Can Stick To